When standard therapies (like steroids or cyclosporine) have failed or are not well-tolerated, there is hope for patients with FSGS. Dealing with Focal Segmental Glomerulosclerosis is challenging, but determining your eligibility for the innovative LIPOSORBER treatment is the necessary first step toward finding a path to potential remission. Please answer the following questions to see if you are a candidate for this therapeutic option.
Determine Your Eligibility for FSGS Treatment
The following short questionnaire helps us understand if your medical history aligns with the criteria for LIPOSORBER therapy. Your responses are confidential.
Is LIPOSORBER Right For You?
LIPOSORBER is a therapeutic plasma apheresis system specifically designed for patients with certain cholesterol-related diseases, which includes some patients suffering from Focal Segmental Glomerulosclerosis (FSGS). The ideal candidate typically meets these strict criteria:
- Diagnosis: Primary FSGS or post-transplant FSGS recurrence.
- Treatment History: Persistent proteinuria despite trying and failing standard treatment options like steroids or cyclosporine.
- Kidney Function: A GFR (Glomerular Filtration Rate) above 60 mL/min/1.73 m^2.
Completing the form above is the quickest way to confirm if this treatment may be an option for your unique condition.